Harmony Biosciences Holdings, Inc. HRMY

Latest FY: 2025 Healthcare Biotechnology
Market Price $41.10
Market Cap $2.38B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.2% YoY
$3.22B
3-Yr CAGR: 3.7%
Net Income ↑9.1% YoY
$158.69M
Net Margin: 4.9%
Free Cash Flow ↑59.1% YoY
$347.89M
FCF Yield: 14.62%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
4.4%
ROA: 12.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (HRMY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $2,653.4M $220.4M $-266.4M $-111.5M
FY 2018 $2,531.9M -4.6% $335.7M $-145.8M +45.3% $-304.5M
FY 2019 $2,592.6M +2.4% $4.4M $-239.5M -64.3% $-75.4M $-75.6M
FY 2020 $2,830.4M +9.2% $132.0M $-56.4M +76.5% 0.00% $-3.0M $-3.0M +96.0%
FY 2021 $2,628.9M -7.1% $249.9M $29.8M +152.8% 0.00% $98.6M $98.3M +3,389.6%
FY 2022 $2,890.0M +9.9% $354.4M $51.1M +71.5% 0.00% $144.5M $144.3M +46.9%
FY 2023 $2,966.1M +2.6% $460.8M $128.9M +152.2% 0.00% $219.4M $219.1M +51.8%
FY 2024 $3,260.3M +9.9% $557.9M $145.5M +12.9% 0.00% $219.8M $218.7M -0.2%
FY 2025 $3,219.6M -1.2% $670.1M $158.7M +9.1% 0.00% $348.2M $347.9M +59.1%
$

Valuation

Market Price $41.10
Market Cap $2.38B
Enterprise Value $1.79B
P/E Ratio N/A
P/B Ratio 0.66
FCF Yield 14.62%
Dividend Yield 0.00%
Shares Outstanding 57,892,700
%

Profitability & Margins

Gross Margin 20.81%
Operating Margin 6.47%
Net Margin 4.93%
Return on Equity (ROE) 4.38%
Return on Assets (ROA) 12.48%
Asset Turnover 2.53x
Revenue 3-Yr CAGR 3.67%
🛡️

Financial Health & Liquidity

Current Ratio 2.73
Cash Ratio 151.81
Debt / Equity 0.045
Debt / Assets 0.129
Cash & Equivalents $752.50M
Total Debt $163.66M
Book Value / Share $62.62
💧

Cash Flow Efficiency

Operating Cash Flow $348.20M
Capital Expenditures (CapEx) $310.00K
Free Cash Flow $347.89M
OCF / Revenue 10.81%
FCF / Revenue 10.81%
FCF 3-Yr CAGR 34.09%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $62.62
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.27B
Total Liabilities -$2.35B
Stockholders' Equity $3.63B
Current Assets $13.52M
Current Liabilities $4.96M